Is choice of antihypertensive agent important in improving cardiovascular outcomes in high-risk hypertensive patients?
- PMID: 19782453
- PMCID: PMC4517590
- DOI: 10.1053/j.ajkd.2009.08.003
Is choice of antihypertensive agent important in improving cardiovascular outcomes in high-risk hypertensive patients?
Comment on
-
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182. N Engl J Med. 2008. PMID: 19052124 Clinical Trial.
References
-
- Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–223. - PubMed
-
- Ezzati M, Lopez AD, Rodgers A, et al. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–1360. - PubMed
-
- Turnbull F, Neal B, Algert C, et al. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165(12):1410–1419. - PubMed
-
- Neal B, MacMahon S, Chapman N Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356(9246):1955–1964. - PubMed
-
- Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med. 1997;126(10):761–767. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources